Pending — not yet graded
“Maintains a 'Buy' call on Pine Labs, increasing its target price to ₹230. The new UPI acquiring model, with its contractual and recurring revenue stream, is expected to benefit the company, making its payment business more resilient. Estimates Pine Labs to generate ₹155 crore in UPI MDR revenue in FY28.”
Pine LabsBullishCalled 16 Sep 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.